Skip to content
Review Open access

Bidirectional regulation between ferroptosis and tumor-associated macrophages: mechanisms, strategies, and therapeutic perspectives

Aug 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 97 references
Medicine

TL;DR

The framework thereby explains how TAM state, tumor niche, and treatment schedule redirect a common oxidative insult without proposing an additional ferroptosis execution pathway.

Abstract

Ferroptosis arises when iron-dependent phospholipid peroxidation overwhelms the system xc−–glutathione–GPX4 axis and parallel antioxidant defenses. Within tumors, however, the immune consequence of this death process depends on how iron and oxidized material move between malignant and immune compartments. Tumor-associated macrophages (TAMs) occupy this interface because they recycle iron, engulf dying cells and oxidized membranes, and modify the redox state of neighboring cells. These activities may confine injury to tumor cells, propagate lipid damage into immune cells, or protect malignant cells through vesicle cargo and antioxidant exchange. Ferroptotic death combines loss of viability with iron-dependent phospholipid peroxidation attenuated by an appropriate inhibitor, with genetic corroboration where feasible. Tumor-restricted ferroptosis can support antigen handling while macrophage and dendritic-cell functions remain intact. As oxidized material exceeds local clearance and antioxidant capacity, the same insult can impair CD8+ T cells and phagocytic macrophages and favor immune suppression. Three linked modules organize this process: iron-flux redistribution, lipid-hydroperoxide spectra and receptor sensing, and phagocytic clearance and antioxidant buffering. Iron flux identifies the first injured compartment, lipid species and receptor distribution shape the ensuing immune response, and clearance determines the duration and spread of injury. The framework thereby explains how TAM state, tumor niche, and treatment schedule redirect a common oxidative insult without proposing an additional ferroptosis execution pathway. Clinical translation will require ferroptosis to remain concentrated in the intended compartment while CD8+ T cells and homeostatic phagocytes retain function. Bulk iron, oxidative markers, and transcriptomic signatures provide complementary signals but cannot resolve the injured cell population.

Read PDF

Similar papers

Review Open access Sep 2026

Ferroptosis at the tumor–immune interface: seeking a middle ground between tumor eradication and T-cell fitness

Ferroptosis is an iron-dependent form of regulated cell death, which is manifested by the lethal accumulation of lipid peroxides. While it is considered a promising strategy for the elimination of apoptosis-resistant cancer cells, growing evidence highlights the dual role of ferroptosis within the tumor microenvi...

A. Jurga, Natalia Leśniowska, Olga Malik et al. · 0 citations
Review Oct 2026

Ferroptosis-Targeted Strategies to Counter Hypoxia- and Acidosis-Associated Immunosuppression in the Tumor Microenvironment.

Immunotherapy has transformed cancer treatment, yet its efficacy in solid tumors remains constrained by primary or acquired resistance. Increasing evidence suggests that ferroptosis sensitivity is shaped not only by tumor intrinsic metabolic programs but also by the surrounding microenvironment. Ferroptosis, an iron-de...

Wan-Qiu Zhang, Xiao-Fei Zhang, Si-Lin Kong et al. · 0 citations
Review Open access Oct 2026

Ferroptosis in the tumor immune microenvironment: from danger signals to immune reprogramming

Immune-checkpoint blockade has changed cancer therapy, yet durable responses remain limited by immune exclusion, myeloid suppression and metabolic adaptation within the tumor immune microenvironment. Ferroptosis, an iron-dependent form of lipid-peroxidation-driven regulated cell death, offers a mechanistic bridge bet...

Qing-Miao Shi, Bing-Qian Tan, Hui-Wu Xing · 0 citations
Review Open access Sep 2026

Modulation of Ferroptosis Bridges Radiotherapy and Immunotherapy to Improve Cancer Treatment Outcomes.

Programmed cell death evasion fuels malignant progression and undermines therapeutic efficacy across diverse neoplasms. Ferroptosis, an iron-driven membrane lipid oxidation that culminates in catastrophic membrane integrity loss, has emerged as a metabolically distinct liability amenable to therapeutic exploitation thr...

Hong-Xiang Zhao, Xue Gao, R. Xie et al. · 0 citations
Review Open access Sep 2026

The subcellular landscape of ferroptosis: A cellular organelle perspective

Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation. Its execution depends not only on the amount of lipid peroxides, but also on where oxidizable lipids, redox-active iron, reactive oxygen species, and antioxidant defenses are distributed within cells. This review summarizes curre...

Jun-Ren Dai, Xing-Feng Du, Ying Hu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.